Iap Antagonists

IAP Antagonists is a class of endogenous or synthetic molecules that function as negative regulators of Inhibitor of Apoptosis Proteins by selectively binding to and neutralizing their anti-apoptotic activity, thereby promoting caspase activation and facilitating the intrinsic apoptotic pathway.

190

Publications

20.2K

Citations

1.3K

Authors

365

Institutions

Publications per year

2017–2026

49

Variants

Inhibitor Of Apoptosis Protein Antagonists

Authors

1.3K

  1. WJ
    Wayne J. Fairbrother

    PDL BioPharma (United States), United States

    13 publications · 2.3K citations

    13

    h-index

  2. JS
    John Silke

    Walter and Eliza Hall Institute of Medical Research, Australia

    13 publications · 5.1K citations

    13

    h-index

  3. DV
    Domagoj Vucic

    Gene Therapy Laboratory, France

    12 publications · 2.9K citations

    12

    h-index

  4. DL
    David L. Vaux

    Walter and Eliza Hall Institute of Medical Research, Australia

    10 publications · 4.8K citations

    10

    h-index

  5. JA
    John A. Flygare

    The University of Melbourne, Australia

    9 publications · 2K citations

    9

    h-index

1–5 of 1.3K

Venues

  1. Journal of Medicinal Chemistry

    17 publications · 1.7K citations

    17

    h-index

  2. Journal of Biological Chemistry

    JBC · 12 publications · 1.4K citations

    12

    h-index

  3. Cell Death and Disease

    8 publications · 381 citations

    8

    h-index

  4. Molecular Cancer Therapeutics

    MCT · 7 publications · 439 citations

    7

    h-index

  5. APOPTOSIS

    6 publications · 213 citations

    6

    h-index

1–5